DiscoverTT HealthWatchOral med for obesity, stem cells after heart failure, blood markers and MS, and predicting atherosclerosis
Oral med for obesity, stem cells after heart failure, blood markers and MS, and predicting atherosclerosis

Oral med for obesity, stem cells after heart failure, blood markers and MS, and predicting atherosclerosis

Update: 2025-11-071
Share

Description

Program notes:

0:37 An oral med for obesity

1:37 Five to 10% stopped medication

2:35 Need head-to-head trials with injectable

3:00 Stem cell infusion after MI and heart failure

4:01 Reduced heart failure in recipients

5:01 Twice as many in the control arm

6:01 Moving past BMI in predicting atherosclerosis

7:01 Especially in overweight but not obese

8:01 Almost 3000 participants in Brazil

8:25 Blood samples precede MS

9:04 Seen seven years beforehand

10:02 Twin studies and relatives

11:03 Way to intervene earlier

11:15 Applaud OpenAI

13:00 End

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Oral med for obesity, stem cells after heart failure, blood markers and MS, and predicting atherosclerosis

Oral med for obesity, stem cells after heart failure, blood markers and MS, and predicting atherosclerosis

David Peregrino